Clinical trial
A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and…
NCT00185094 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00185094 |
|---|---|
| Title | A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin |
| Official title | The Effects of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on Insulin Sensitivity in Overweight and Obese Subjects With Hypertension |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Insulin Resistance, Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | Olmesartan medoxomil, Losartan potassium, Atenolol |
| Enrollment | 60 |
| Start date | Feb 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 23, 2005 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: